Nicotiana benthamiana α-galactosidase A1.1 can functionally complement human α-galactosidase A deficiency associated with Fabry disease

Author(s):
Kytidou, K.; Beekwilder, J.; Artola, M.; Meel, E. van; Wilbers, R.H.P.; Moolenaar, G.F.; Goosen, N.; Ferraz, M.J.; Katzy, R.; Voskamp, P.; Florea, B.I. (0000-0001-7114-2266); Hokke, C.H.; Overkleeft, H.S. (0000-0001-6992-4760); Schots, A.; Bosch, D.; Pannu, N.; Aerts, J.M.F.G. (0000-0001-8168-2565)
Published
2018
Publication type
Article / Letter to editor
glycoside hydrolaseplanthumanenzyme inhibitorglycolipidfluorescenceprotein expressionenzyme purificationenzyme structure-galactosidaseenzyme-replacement therapyFabry diseaseglycosphingolipidsNicotiana benthamianahomologuelysosomal storage disorderrecombinant enzymeglycosphingolipid
Date issued
2018-06-29
Language
English
Is part of
Journal of Biological Chemistry (2018), Vol. 293, no. 26, p. 10042-10058
hdl
1887/67285
doi
10.1074/jbc.RA118.001774
URL
http://www.jbc.org/content/293/26/10042